Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nozza

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Computer Methods and Programs in Biomedicine|October 1, 2013
Identification and experimental validation of an HIV model for HAART treated patientsG Pannocchia, E Morano, M Laurino, et al.
Clinical Immunology (Orlando, Fla.)|April 5, 2001
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individualsC Bovolenta, L Camorali, M Mauri, et al.
HIV Medicine|December 18, 2009
Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2S Ghezzi, F Pacciarini, S Nozza, et al.
The Journal of Antimicrobial Chemotherapy|March 5, 2020
Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2)F Maggiolo, N Gianotti, L Comi, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2016
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ARTS Chiappetta, M Ripa, L Galli, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 16, 2018
Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in ItalyV Damuzzo, A Russi, M Chiumente, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
The effect of HAART on humoral immune response in primary HIV-1 infected patientsC Pastori, C Barassi, F Lillo, et al.
Antiviral Research|May 28, 2014
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patientsA Calcagno, L Marinaro, S Nozza, et al.
HIV Medicine|July 16, 2010
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patientsN Gianotti, F Visco, L Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 22, 2010
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruptionF Canducci, B Barda, E Ceresola, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Computer Methods and Programs in Biomedicine|October 1, 2013
Identification and experimental validation of an HIV model for HAART treated patientsG Pannocchia, E Morano, M Laurino, et al.
Clinical Immunology (Orlando, Fla.)|April 5, 2001
Expression and activation of a C-terminal truncated isoform of STAT5 (STAT5 Delta) following interleukin 2 administration or AZT monotherapy in HIV-infected individualsC Bovolenta, L Camorali, M Mauri, et al.
HIV Medicine|December 18, 2009
Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2S Ghezzi, F Pacciarini, S Nozza, et al.
The Journal of Antimicrobial Chemotherapy|March 5, 2020
Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2)F Maggiolo, N Gianotti, L Comi, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2016
Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ARTS Chiappetta, M Ripa, L Galli, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 16, 2018
Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in ItalyV Damuzzo, A Russi, M Chiumente, et al.
Journal of Biological Regulators and Homeostatic Agents|May 11, 2002
The effect of HAART on humoral immune response in primary HIV-1 infected patientsC Pastori, C Barassi, F Lillo, et al.
Antiviral Research|May 28, 2014
Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patientsA Calcagno, L Marinaro, S Nozza, et al.
HIV Medicine|July 16, 2010
Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patientsN Gianotti, F Visco, L Galli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 22, 2010
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruptionF Canducci, B Barda, E Ceresola, et al.
Pageof 2